could glp-1 be the next mental health drug Receptor Agonists in Mood Disorders: A Psychiatric Perspective GLP-1 Medications and Mental Health
Description
Rodriguez R, Moreno M, Lee AY, Godoy-Lugo JA, Nakano D, Nishiyama A, et al

H., Thieu V

There absolute garbage in the worst

However, CagriSema and retatrutide (both in late-stage development) more closely match tirzepatide weight loss results , with CagriSema achieving 20% and retatrutide achieving up to 29% body weight reduction in trials
"I am interested in the cardiovascular protective effects of GLP-1 receptor agonists given my family history of heart disease" is a perfectly valid opening statement

Garcia Luna, C
